Nishad D K, Rawat H S, Singh T, Bhatnagar A, Mittal G
Department of Nuclear Medicine, Institute of Nuclear Medicine & Allied Sciences, Defence Research and Development Organization, Ministry of Defence, Delhi, India.
Hum Exp Toxicol. 2019 Jan;38(1):106-117. doi: 10.1177/0960327118781929. Epub 2018 Jun 18.
: This study examined the decorporation potential of lansoprazole (LNP) as radioactivity decorporation agent for radiothallium (Tl) in internally contaminated BALB/c mice and New Zealand White rabbits using radiometry and gamma scintigraphy.
: Animals were divided into three groups, that is, control, pretreatment-1 (1X LNP), and pretreatment-2 (2X LNP). Mice received LNP intraperitoneally, while in rabbits LNP was given through oral route 0.5 and 1.5 h before radiothallium administration, respectively. Mice and rabbits used in the experiment were administered 1.48 and 11.1 MBq radiothallium (TlCl) through intravenous and oral route, respectively. Once started as prophylactic, LNP was continued as therapeutic twice a day till the end of study period. Radiometry and gamma scintigraphy were used to monitor radiothallium retention and uptake patterns in animals. Gamma scintigraphic images of rabbits were taken at different time intervals up to 72 h and were analyzed for comparative uptake pattern of TlCl in all the groups.
: LNP treatment significantly increased the Tl elimination over untreated control and considerably reduced the retention of Tl in various tissues and organs. Decrease in radiothallium uptake up to 40% was observed in LNP-treated mice as compared to untreated control. While in rabbits, whole-body radioactivity burden at 72 h was found to be 31.24%, 26%, and 18.54% in untreated control, 9 and 18 mg/kg LNP-treated groups, respectively.
: LNP exhibited dose-dependent decorporation potential to effectively enhance the elimination of Tl in mice and rabbits experimentally contaminated with TlCl.
本研究使用放射性测量法和γ闪烁扫描法,研究了兰索拉唑(LNP)作为放射性铊(Tl)体内污染的BALB/c小鼠和新西兰白兔体内放射性去污剂的去污潜力。
将动物分为三组,即对照组、预处理-1组(1倍剂量LNP)和预处理-2组(2倍剂量LNP)。小鼠腹腔注射LNP,而在兔子中,分别在给予放射性铊前0.5小时和1.5小时通过口服途径给予LNP。实验中使用的小鼠和兔子分别通过静脉内和口服途径给予1.48和11.1 MBq放射性铊(TlCl)。一旦开始作为预防性给药,LNP持续作为治疗性药物每天给药两次,直至研究期结束。使用放射性测量法和γ闪烁扫描法监测动物体内放射性铊的滞留和摄取模式。在长达72小时的不同时间间隔拍摄兔子的γ闪烁扫描图像,并分析所有组中TlCl的比较摄取模式。
与未处理的对照组相比,LNP处理显著增加了铊的消除,并大大降低了铊在各种组织和器官中的滞留。与未处理的对照组相比,LNP处理的小鼠中放射性铊摄取减少了高达40%。而在兔子中,72小时时未处理的对照组、9和18 mg/kg LNP处理组的全身放射性负担分别为31.24%、26%和18.54%。
LNP表现出剂量依赖性去污潜力,可有效增强实验性受TlCl污染的小鼠和兔子体内铊的消除。